SPC478
Retífanlímab
Status:
VeittApplication date:
29.7.2024Application published:
15.8.2024Grant published:
15.12.2025
Max expiry date:
23.4.2039Medicine name:
ZynyzMedicine for children:
No
Timeline
Today
29.7.2024Application
15.8.2024Publication
15.12.2025Registration
23.4.2039Expires
Marketing license
IS authorization number:
EU/1/24/1800Date:
15.5.2024
Foreign authorization number:
EU/1/24/1800Date:
19.4.2024
Owner
Name:
MacroGenics, Inc.Address:
9704 Medical Center Drive, Rockville, MD 20850 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3328419
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025